Indication · Otolaryngology (ENT)
Tinnitus
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
48
Cleared or approved since 2000
PMA and De Novo
1
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
20
158 device trials in all
Devices
47 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Tinnitus Sound Generator Module
GN Hearing A/S · 510(k) · Masker, Tinnitus · newest 2020 · 3 decisions
46 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal TinnitusPivotal-lookingRecruiting
University of Dublin, Trinity CollegeAcademic, hospital or other
NCT07393880 · 100 participants (planned) · Start Jun 30, 2026 · Primary completion Sep 30, 2028
Device: Real NITESGON; Sham NITESGON · For: Tinnitus, Subjective; Tinnitus; Chronic Tinnitus
Sites: Dublin, Ireland
157 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on tinnitus across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.